核心纳米治疗糖尿病白内障和视网膜病变:当前最先进的技术和翻译挑战
Gitika Kumari1, Sourabh Kundu1, Paras Famta1
1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, Balanagar, Hyderabad, 500037, Telangana, India.
Drug delivery and translational research
|September 19, 2025
概括
纳米技术为糖尿病的眼睛疾病提供先进的解决方案,如视网膜病变和白内障. 核心外纳米粒子提供有针对性的,可控的药物输送,改善生物可用性和减少毒性,以获得更好的视觉结果.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 糖尿病视网膜病变 (DR) 和糖尿病白内障 (DC) 是全球导致失明的主要原因.
- 目前对DR和DC的治疗方法有局限性,包括侵入性和患者不合格.
- 对于眼科疾病而言,急需采用更少侵入性和更有效的治疗策略.
研究的目的:
- 审查纳米技术的应用,特别是核心外纳米粒子,用于治疗糖尿病眼部并发症.
- 讨论纳米颗粒在眼睛组织药物输送中的优势.
- 突出核心外纳米颗粒的潜力,提高治疗效率和降低毒性.
主要方法:
- 对眼科药物输送中的纳米技术现有文献的审查.
- 讨论纳米粒子特征,包括表面修饰和向连接体.
- 分析核心外纳米粒子特性,如组织热带性,受控释放和稳定性.
- 检查证明纳米颗粒系统有效性的临床前研究.
主要成果:
- 纳米粒子提供增强的生物可用性和易于表面修饰的目标药物输送.
- 核心外纳米颗粒提供受控的药物释放,刺激反应和改善眼内积累.
- 临床前研究表明,纳米颗粒物输送系统对糖尿病眼病的治疗疗效有所提高.
- 与传统治疗相比,基于纳米粒子的方法显示出降低毒性的潜力.
结论:
- 核心外纳米颗粒代表了糖尿病视网膜病变和白内障的有前途的先进治疗干预.
- 纳米技术可以实现时空控制的药物输送,克服当前治疗方法的局限性.
- 需要进一步的研究和临床转化,以克服核心纳米粒子的扩展挑战.
相关概念视频
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...


